Can-Fite(CANF) - 2022 Q3 - Quarterly Report

Exhibit 99.1 Can-Fite Reports Third Quarter 2022 Financial Results & Provides Clinical Update PETACH TIKVA, Israel, November 25, 2022 -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced financial results for the quarter ended September 30, 2022. Corporate and Clinical Development Highlights Include: Complete Clearance of Cancer in a Patient Treated ...